share_log

康希諾生物：自願公告 - 控股股東及執行董事擬增持股份

CANSINOBIO: VOLUNTARY ANNOUNCEMENT - PROPOSED INCREASE IN SHAREHOLDING BY CONTROLLING SHAREHOLDERS AND EXECUTIVE DIRECTORS

Hong Kong Stock Exchange ·  Jun 21 19:50
Summary by Futu AI
康希諾生物股份公司（「本公司」）於2024年6月21日宣布，公司董事長兼首席執行官Yu博士、首席運營官Chao博士、首席科學官朱博士及首席商務官王女士（統稱「擬增持團體」）計劃於未來六個月內自公開市場增持不超過港幣10百萬元的公司H股股份。擬增持團體表示，此舉是基於對公司未來發展前景和潛力的堅定信心，並認為本公司具有長期投資價值。增持股份將作為中長期投資，且擬增持團體無意於增持後六個月內出售該等股份。擬增持團體成員將使用自有或自籌資金進行增持，並確保增持後不會觸發強制要約責任。董事會表示，增持計劃將不影響公司的公眾持股量。股東及潛在投資者應注意，增持股份的決定權屬於擬增持團體，且增持是否進行尚無法保證。
康希諾生物股份公司（「本公司」）於2024年6月21日宣布，公司董事長兼首席執行官Yu博士、首席運營官Chao博士、首席科學官朱博士及首席商務官王女士（統稱「擬增持團體」）計劃於未來六個月內自公開市場增持不超過港幣10百萬元的公司H股股份。擬增持團體表示，此舉是基於對公司未來發展前景和潛力的堅定信心，並認為本公司具有長期投資價值。增持股份將作為中長期投資，且擬增持團體無意於增持後六個月內出售該等股份。擬增持團體成員將使用自有或自籌資金進行增持，並確保增持後不會觸發強制要約責任。董事會表示，增持計劃將不影響公司的公眾持股量。股東及潛在投資者應注意，增持股份的決定權屬於擬增持團體，且增持是否進行尚無法保證。
Cansinobio announced on June 21, 2024 that the company's Chairman and CEO, Dr. Yu, COO Dr. Chao, Chief Scientific Officer Dr. Zhu, and Chief Business Officer Ms. Wang (collectively, the "Shareholding Group") plan to increase their holdings of the company's H shares on the public market by no more than HKD 10 million within the next six months. The Shareholding Group stated that this is based on their firm confidence in the company's future development prospects and potential and that the company has long-term investment value. The increased shares will be held for medium to long-term investment, and the Shareholding Group has no intention of selling such stocks within six months after the increase. The Shareholding Group members...Show More
Cansinobio announced on June 21, 2024 that the company's Chairman and CEO, Dr. Yu, COO Dr. Chao, Chief Scientific Officer Dr. Zhu, and Chief Business Officer Ms. Wang (collectively, the "Shareholding Group") plan to increase their holdings of the company's H shares on the public market by no more than HKD 10 million within the next six months. The Shareholding Group stated that this is based on their firm confidence in the company's future development prospects and potential and that the company has long-term investment value. The increased shares will be held for medium to long-term investment, and the Shareholding Group has no intention of selling such stocks within six months after the increase. The Shareholding Group members will use their own or self-raised funds for the shareholding increase and ensure that there will be no mandatory offer obligation triggered after the increase. The Board of Directors stated that the shareholding increase plan will not affect the company's public shareholding. Shareholders and potential investors should be aware that the decision to increase the holdings belongs to the Shareholding Group, and whether the increase will take place cannot be guaranteed.

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.